U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2020
742
Name Type Language
SACITUZUMAB GOVITECAN
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
hRS7SN38
Code English
HRS7-SN38-ANTIBODY-DRUG-CONJUGATE
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2) (HUMAN-MUS MUSCULUS MONOCLONAL HRS7 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HRS7 K-CHAIN, DIMER, HEXAKIS(THIOETHER) WITH ( 4S)-4-((((4-(((2 S)-2 -( 4-AM INOBU
Common Name English
HRS7-SN38
Code English
SACITUZUMAB GOVITECAN [MI]
Common Name English
SACITUZUMAB GOVITECAN [USAN]
Common Name English
IMMU-132
Code English
Sacituzumab govitecan [WHO-DD]
Common Name English
sacituzumab govitecan [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 415413
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
FDA ORPHAN DRUG 433514
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
FDA ORPHAN DRUG 769520
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
NCI_THESAURUS C129823
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
NCI_THESAURUS C1512
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
Code System Code Type Description
CAS
1491917-83-9
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
PRIMARY
NCI_THESAURUS
C102783
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID401335985
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
PRIMARY
MERCK INDEX
m12201
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
INN
10097
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
USAN
BC-91
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
ChEMBL
CHEMBL3545262
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
PRIMARY
WIKIPEDIA
Sacituzumab govitecan
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
RXCUI
2360232
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
FDA UNII
M9BYU8XDQ6
Created by admin on Sat Dec 16 08:53:08 GMT 2023 , Edited by admin on Sat Dec 16 08:53:08 GMT 2023
PRIMARY
DRUG BANK
DB12893
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
PRIMARY
DAILYMED
M9BYU8XDQ6
Created by admin on Sat Dec 16 08:53:07 GMT 2023 , Edited by admin on Sat Dec 16 08:53:07 GMT 2023
PRIMARY
METABOLITE ACTIVE (PARENT)
Structure of 7-ETHYL-10-HYDROXYCAMPTOTHECIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966